US · Healthcare

Maravai Lifesciences Holdings Inc (MRVI)

Biotechnology

Maravai Lifesciences Holdings Inc (MRVI) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MRVI

P/E ratio

18.00

Maravai Lifesciences Holdings Inc (MRVI) — FAQ

What is MRVI's P/E ratio?

The price-to-earnings (P/E) ratio for Maravai Lifesciences Holdings Inc (MRVI) is 18.00 (data as of 2026-03-24).

Does Maravai Lifesciences Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Maravai Lifesciences Holdings Inc (MRVI). Check the MyAverix Finance app for the latest dividend data.

What sector is Maravai Lifesciences Holdings Inc in?

Maravai Lifesciences Holdings Inc (MRVI) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MRVI listed on?

MRVI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)